Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
New drug trial aims to protect livers from scarring disease
Disease control Not yet recruitingThis study is testing whether a drug called saroglitazar magnesium can help people with primary biliary cholangitis (PBC), a chronic liver disease. It will compare the drug to a placebo in about 386 adults who are already on standard treatment. The main goal is to see if the drug…
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
New hope for liver disease patients who Don't respond to standard treatment
Disease control Not yet recruitingThis study is testing whether a medication called saroglitazar magnesium can help control primary biliary cholangitis, a chronic liver disease. The trial will involve 89 adults who either don't respond well to or can't tolerate the standard treatment. Participants will receive ei…
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC